Top Stories
-
Researchers, physician-scientists, trainees, and community members across Columbia gathered to explore the rapidly evolving field of cancer metabolism.
-
Adana Llanos, PhD, MPH, discusses the latest in breast cancer inequities following the American Cancer Society (ACS) biennial update of breast cancer statistics among women in the United States.
Topic
-
A new paper from Elham Azizi's lab and collaborators has been accepted in Genome Research, marking a significant advancement in the study of dynamic single-cell interactions.
-
Ricardo Cruz-Acuña, PhD' s hunger for research and learning began early. Now, with his own lab at the HICCC, he advocates for the new generation of underrepresented minority scientists.
Topic
Latest News
- May 13, 2022
Congratulations to Dr. Benjamin Izar, a recipient of the Schaefer Research Scholar award, supporting his work in drug resistance and novel immunotherapies.
Topic
-
Source:
Columbia EngineeringMay 2, 2022Researchers have developed a multi-organ chip, a novel platform that captures the biology of organ interactions in the body, enabling a new way to study disease progression and treatments.
- April 29, 2022
Expert geneticist Dr. Wendy Chung takes us through the ever-evolving genetics landscape and its revolutionary impact in cancer.
Topic
- April 27, 2022
Physician-scientists at the Herbert Irving Comprehensive Cancer Center are pioneering new tools--3D organoids--for treating head and neck cancer.
Topic
- April 19, 2022
Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.
Topic
- April 14, 2022
In Notes from the Lab, we spotlight the Giancotti lab and new research identifying factors that sustain prostate cancer cells that have become resistant to androgen receptor (AR) therapy.
Topic
-
Source:
CUIMC NewsroomApril 13, 2022A new instrument at Columbia will help scientists uncover the full potential of heavy ion radiation therapy and could improve treatment of pancreatic cancer and other difficult-to-treat tumors.
Topic
- March 22, 2022
Researchers have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells.
- March 2, 2022
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
Topic
- January 31, 2022
The Trainee Associate Member Pilot Grants Program aims to support up-and-coming graduate and medical student and post-graduate researchers across Columbia working on all aspects of cancer research.
Topic
